Compare ESPR & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | BFS |
|---|---|---|
| Founded | 2008 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 898.5M | 759.2M |
| IPO Year | 2013 | 1993 |
| Metric | ESPR | BFS |
|---|---|---|
| Price | $3.89 | $31.62 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 75.0K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 7.48% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $303,802,000.00 | $282,618,000.00 |
| Revenue This Year | $26.11 | $8.14 |
| Revenue Next Year | N/A | $5.75 |
| P/E Ratio | ★ N/A | $27.66 |
| Revenue Growth | 2.83 | ★ 5.61 |
| 52 Week Low | $0.69 | $29.16 |
| 52 Week High | $4.13 | $39.15 |
| Indicator | ESPR | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 54.60 |
| Support Level | $3.87 | $31.00 |
| Resistance Level | $4.05 | $32.37 |
| Average True Range (ATR) | 0.20 | 0.57 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 50.00 | 54.79 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.